Suiseng Coli /C Suspension for injection for pigs Ireland - English - HPRA (Health Products Regulatory Authority)

suiseng coli /c suspension for injection for pigs

laboratorios hipra s.a. - f4ab fimbrial adhesin of e.coli; f4ac fimbrial adhesin of e.coli; f5 fimbrial adhesin of e.coli; f6 fimbrial adhesin of e. coli; lt enterotoxoid of e. coli; clostridium perfringens, type c toxoid; clostridium novyi, type b toxoid - suspension for injection - . - escherichia + clostridium

Suiseng Suspension for injection for pigs Ireland - English - HPRA (Health Products Regulatory Authority)

suiseng suspension for injection for pigs

laboratorios hipra s.a. - f4ab fimbrial adhesin of e.coli; f4ac fimbrial adhesin of e.coli; f5 fimbrial adhesin of e.coli; f6 fimbrial adhesin of e. coli; lt enterotoxoid of e. coli; clostridium perfringens, type c toxoid; clostridium novyi, type b toxoid - suspension for injection - . - escherichia + clostridium - pigs - immunological - inactivated vaccine

SUISENG SUSPENSION FOR INJECTION FOR PIGS Ireland - English - HPRA (Health Products Regulatory Authority)

suiseng suspension for injection for pigs

laboratorios hipra s.a. - f4ab fimbrial adhesin of e.coli, f4ac fimbrial adhesin of e.coli, f5 fimbrial adhesin of e.coli, f6 fimbrial adhesin of e. coli, lt enterotoxoid of e. coli, clostridium perfringens type c toxoid, clostridium novyi type b toxoid - suspension for injection - unknown - escherichia vaccine + clostridium vaccine - porcine - immunological - inactivated vaccine

Enteroporc Coli European Union - English - EMA (European Medicines Agency)

enteroporc coli

ceva santé animale - inactivated fimbrial adhesins of escherichia coli f4ab, inactivated fimbrial adhesins of escherichia coli f4ac, inactivated fimbrial adhesins of escherichia coli f5, inactivated fimbrial adhesins of escherichia coli f6 - immunologicals for suidae - pigs - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6.

Enteroporc Coli AC European Union - English - EMA (European Medicines Agency)

enteroporc coli ac

ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - pigs - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:-           clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6-           clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins-           clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin

Suiseng Each 2 mL (dose) contains:   E. coli (F4ab fimbrial adhesin) E. coli (F4ac fimbrial adhesin) E. coli (F5 fimbrial adhesin) E. coli (F6 fimbrial adhesin) LT Enterotoxoid of E.coli B-Toxoid Clostridium perfringens, Type C á-Toxoid Clostridium novyi   $5% ER * »78% ER70 59% ER30 80% ER25   5% ER 70 5% ERS >50% ER 120 Suspension for Injection   (IM) Philippines - English - FDA (Food And Drug Administration)

suiseng each 2 ml (dose) contains: e. coli (f4ab fimbrial adhesin) e. coli (f4ac fimbrial adhesin) e. coli (f5 fimbrial adhesin) e. coli (f6 fimbrial adhesin) lt enterotoxoid of e.coli b-toxoid clostridium perfringens, type c á-toxoid clostridium novyi $5% er * »78% er70 59% er30 80% er25 5% er 70 5% ers >50% er 120 suspension for injection (im)

hipra philippines, inc.; distributor: hipra philippines, inc. - escherichia coli fimbrial adhesins , e. coli lt enterotoxoid , clostridium perfringens b-toxoid , c. novyi type b a-toxoid vaccine (vet.) - suspension for injection (im) - each 2 ml (dose) contains: e. coli (f4ab fimbrial adhesin) e. coli (f4ac fimbrial adhesin) e. coli (f5 fimbrial adhesin) e. coli (f6 fimbrial adhesin) lt enterotoxoid of e.coli b-toxoid clostridium perfringens, type c á-toxoid clostridium novyi $5% er * »78% er70 59% er30 80% er25 5% er 70 5% ers >50% er 120

Neocolipor Each 2 mL (dose) contains:   Escherichia coli K12 (F4ab, F4ac, F4ad Factor Antigen) Escherichia coli K12 (F5 Factor Antigen) Escherichia coli 09 (K9 Factor Antigen) Escherichia coli 0101 (F41 Factor Antigen)   >2.1 SAU.* 21.7 SA U.* 21.4 SA U.* 21.7 SA U.*   "I SAU: .s. to obtain a seroagglutinating antibody titre of 1 log10 inguine pigs Suspension for Injection   (IM) Philippines - English - FDA (Food And Drug Administration)

neocolipor each 2 ml (dose) contains: escherichia coli k12 (f4ab, f4ac, f4ad factor antigen) escherichia coli k12 (f5 factor antigen) escherichia coli 09 (k9 factor antigen) escherichia coli 0101 (f41 factor antigen) >2.1 sau.* 21.7 sa u.* 21.4 sa u.* 21.7 sa u.* "i sau: .s. to obtain a seroagglutinating antibody titre of 1 log10 inguine pigs suspension for injection (im)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - inactivated escherichia coli fimbrial adhesins vaccine (vet.) - suspension for injection (im) - each 2 ml (dose) contains: escherichia coli k12 (f4ab, f4ac, f4ad factor antigen) escherichia coli k12 (f5 factor antigen) escherichia coli 09 (k9 factor antigen) escherichia coli 0101 (f41 factor antigen) >2.1 sau.* 21.7 sa u.* 21.4 sa u.* 21.7 sa u.* "i sau: .s. to obtain a seroagglutinating antibody titre of 1 log10 inguine pigs

Porcilis ColiClos European Union - English - EMA (European Medicines Agency)

porcilis coliclos

intervet international bv - clostridium perfringens type c / escherichia coli f4ab / e. coli f4ac / e. coli f5 / e. coli f6 / e. coli lt - immunologicals - pigs - for the passive immunisation of progeny by active immunisation of sows and gilts to reduce mortality and clinical signs during the first days of life, caused by those escherichia coli strains which express the adhesins f4ab (k88ab), f4ac (k88ac), f5 (k99) or f6 (987p) and caused by clostridium perfringens type c.,

Suiseng Each 2 mL (dose) contains: Escherichia coli Fimbrial Adhesin F4ab   F4ac F5   F6   %65% ER60 278% ER70 279% ER 50 >80% ER35 >55% ER 70 >35% ER25 >50% ER120   E. coli LT Enterotoxoid Clotridium perfringens (Type C) BToxoid Clostridium novyi (Type B) a Toxoid   % ERx: Percentage of immunized rabbits with enzyme immunoassay response. Suspension for Injection   (IM) Philippines - English - FDA (Food And Drug Administration)

suiseng each 2 ml (dose) contains: escherichia coli fimbrial adhesin f4ab f4ac f5 f6 %65% er60 278% er70 279% er 50 >80% er35 >55% er 70 >35% er25 >50% er120 e. coli lt enterotoxoid clotridium perfringens (type c) btoxoid clostridium novyi (type b) a toxoid % erx: percentage of immunized rabbits with enzyme immunoassay response. suspension for injection (im)

hipra philippines inc.; distributor: hipra philippines inc. - inactivated escherichia coli fimbrial adhesin (f4ab, f4ac, f5 and f6) , heat labile (lt) enterotoxoid , clotridium perfringens (type c) b toxoid , clostridium novyi (type b) a toxoid vaccine (vet.) - suspension for injection (im) - each 2 ml (dose) contains: escherichia coli fimbrial adhesin f4ab f4ac f5 f6 %65% er60 278% er70 279% er 50 >80% er35 >55% er 70 >35% er25 >50% er120 e. coli lt enterotoxoid clotridium perfringens (type c) btoxoid clostridium novyi (type b) a toxoid % erx: percentage of immunized rabbits with enzyme immunoassay response.

Porcilis Porcoli DF Formulation:  Each 2 mL (dose) contains:  Escherichia coli F4ab (K88ab) Fimbrial Adhesin (K12 Strain) . Escherichia coli F4ac (K88ac) Fimbrial Adhesin (K12 Strain) Escherichia coli F5 (K99) Fimbrial Adhesin (K12 Strain) Escherichia coli F6 (987P) Fimbrial Adhesin (987P-5 Strain) Escherichia coli LT toxoid (K12 Strain) ..  U – Determinal antigenic mass by ELISA (Enzyme-Lunkei Immunosorbent Assay)  Processed under FDA Memorandum Circular 2021-001.  ≥ 400 U 120 U ≥ 400 U  ≥ 1000 U  > 320 ng Suspension for Injection  (IM) Philippines - English - FDA (Food And Drug Administration)

porcilis porcoli df formulation: each 2 ml (dose) contains: escherichia coli f4ab (k88ab) fimbrial adhesin (k12 strain) . escherichia coli f4ac (k88ac) fimbrial adhesin (k12 strain) escherichia coli f5 (k99) fimbrial adhesin (k12 strain) escherichia coli f6 (987p) fimbrial adhesin (987p-5 strain) escherichia coli lt toxoid (k12 strain) .. u – determinal antigenic mass by elisa (enzyme-lunkei immunosorbent assay) processed under fda memorandum circular 2021-001. ≥ 400 u 120 u ≥ 400 u ≥ 1000 u > 320 ng suspension for injection (im)

msd animal health (phils.), inc. - inactivated escherichia coli fimbrial adhesin , heat labile toxoid (lt) vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: escherichia coli f4ab (k88ab) fimbrial adhesin (k12 strain) . escherichia coli f4ac (k88ac) fimbrial adhesin (k12 strain) escherichia coli f5 (k99) fimbrial adhesin (k12 strain) escherichia coli f6 (987p) fimbrial adhesin (987p-5 strain) escherichia coli lt toxoid (k12 strain) .. u – determinal antigenic mass by elisa (enzyme-lunkei immunosorbent assay) processed under fda memorandum circular 2021-001. ≥ 400 u 120 u ≥ 400 u ≥ 1000 u > 320 ng